Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors

Journal of Clinical Oncology

Volumn 33, Issue 10, 2015, Pages 1104-1111

  Irwin, Melinda L ^a,b   Cartmel, Brenda ^a,b   Gross, Cary P ^a,b   Ercolano, Elizabeth ^a,b   Li, Fangyong ^a,b   Yao, Xiaopan ^a,b   Fiellin, Martha ^a   Capozza, Scott ^a   Rothbard, Marianna ^a   Zhou, Yang ^a,b   Harrigan, Maura ^a   Sanft, Tara ^a,b   Schmitz, Kathryn ^c   Neogi, Tuhina ^d   Hershman, Dawn ^f   Ligibel, Jennifer ^e  

^a YALE UNIVERSITY   (United States)

^b YALE CANCER CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR;

ADULT; AEROBIC EXERCISE; ARTHRALGIA; ARTICLE; BRIEF PAIN INVENTORY; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CONTROLLED STUDY; DISABILITIES OF THE ARM, SHOULDER AND HAND (SCORE); ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HUMAN; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PAIN SEVERITY; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; AGED; BREAST NEOPLASMS; CHEMICALLY INDUCED; DISABILITY; MIDDLE AGED; PAIN MEASUREMENT; PROCEDURES; QUESTIONNAIRE; SURVIVOR; TIME FACTOR; TREATMENT OUTCOME;

AGED; AROMATASE INHIBITORS; ARTHRALGIA; BREAST NEOPLASMS; DISABILITY EVALUATION; EXERCISE THERAPY; FEMALE; HUMANS; MIDDLE AGED; PAIN MEASUREMENT; SURVEYS AND QUESTIONNAIRES; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84982156311     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.57.1547     Document Type: Article

References (33)

1. Goss PE, Ingle JN, Martino S, et al: A randomized trial of letrozole in postmenopausal women after 5 years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1793-1802, 2003
2. Clarke M: Meta-analyses of adjuvant therapies for women with early breast cancer: The Early Breast Cancer Trialists' Collaborative Group overview. Ann Oncol 17:x59-x62, 2006 (suppl 10)
3. Gnant M, Harbeck N, Thomssen C: St. Gallen 2011: Summary of the consensus discussion. Breast Care (Basel) 6:136-141, 2011
4. Burstein HJ, Prestrud AA, Seidenfeld J, et al: American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 28:3784-3796, 2010
5. Murphy CC, Bartholomew LK, Carpentier MY, et al: Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: A systematic review. Breast Cancer Res Treat 134: 459-478, 2012
6. Crew KD, Greenlee H, Capodice J, et al: Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25:3877-3883, 2007
7. Stestak I, Cuzick J, Sapunar F, et al: Risk factors for joint symptoms in patients enrolled in the ATAC trial: A retrospective, exploratory analysis. Lancet Oncol 9:866-872, 2008
8. Hershman DL, Shao T, Kushi LH, et al: Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126:529-538, 2011
9. Henry NL, Giles JT, Ang D, et al: Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res Treat 111:365-372, 2008
10. Mao JJ, Stricker C, Bruner D, et al: Patterns and risk factors associated with aromatase inhibitorrelated arthralgia among breast cancer survivors. Cancer 115:3631-3639, 2009
11. Thomas KS, Muir KR, Doherty M, et al: Home based exercise program for knee pain and knee osteoarthritis. BMJ 325:752, 2002
12. Ballard-Barbash R, Friedenreich CM, Courneya KS, et al: Physical activity, biomarkers and disease outcomes in cancer survivors. J Natl Cancer Inst 104:815-840, 2012
13. Fallowfield LJ, Bliss JM, Porter LS, et al: Quality of life in the Intergroup Exemestane study. J Clin Oncol 24:910-917, 2006
14. Cleeland CS, Ryan KM: Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 23:129-138, 1994
15. Bellamy N, Buchanana WW, Goldsmith CH, et al: Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to anti-rheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833-1840, 1988
16. Kennedy CA, Beaton DE, Solway S, et al: Disabilities of the Arm, Should and Hand (DASH): The DASH and QuickDASH Outcome Measure User's Manual (ed 3). Toronto, Ontario, Canada, Institute for Work and Health, 2011
17. Kriska AM, Knowler WC, LaPorte RE, et al: Development of a questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 13:401-411, 1990
18. Peel AB, Thomas SM, Dittus K, et al: Cardiorespiratory fitness in breast cancer patients: A call for normative values. J Am Heart Assoc 3:e000432, 2014
19. Schmitz KH, Courneya KS, Matthews C, et al: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409-1426, 2010
20. Blair SN, Haskell WL, Ho P, et al: Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 122:794-804, 1985
21. Crew KD, Capodice JL, Greenlee H, et al: Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol 28:1154-1160, 2010
22. Fitzmaurice GM, Laird NM, Ware JH: Applied Longitudinal Analysis. Wiley-Interscience, Hoboken, NJ, 2011, pp122-132
23. Hedeker D, Gibbons RD: Application of randomeffects pattern-mixture models for missing data in longitudinal studies. Psychol Methods 2:64-78, 1997
24. Greenlee H, Crew KD, Shao T, et al: Phase II study of glucosamine with chondroitin on aromatase inhibitorassociated joint symptoms in women with breast cancer. Support Care Cancer 21:1077-1087, 2013
25. Khan QJ, Reddy PS, Kimler BF, et al: Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 119:111-118, 2010
26. Mao JJ, Xie SX, Farrar JT, et al: A randomized trial of electro-acupuncture for arthralgia related to aromatase inhibitor use. Eur J Cancer 50:267-276, 2014
27. Oh B, Kimble B, Costa DS, et al: Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early stage breast cancer: Pilot study. Acupunct Med 31:264-271, 2013
28. Galantino ML, Desai K, Greene L: Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias. Integr Cancer Ther 11:313-320, 2012
29. Galantino ML, Callens ML, Cardena GJ, et al: Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: A feasibility study. Altern Ther Health Med 19:38-44, 2013
30. Chlebowski R: Aromatase inhibitor-associated arthralgias. J Clin Oncol 27:4932-4934, 2009
31. Church TS, Earnest CP, Skinner JS, et al: Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: A randomized controlled trial. JAMA 297:2081-2091, 2007
32. Schmitz KH, Ahmed RL, Troxel A, et al: Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 361:664-673, 2009
33. Jones MD, Booth J, Taylor JL, et al: Aerobic training increases pain tolerance in healthy individuals. Med Sci Sports Exerc 46:1640-1647, 2014